MPH MITTELSTAENDISCHE PHARMA HOLDING AG May 29, 2015
MPH Mittelständische Pharma Holding AG: IFRS results Q1 2015, sales of EUR 52.75 million, net income of EUR 1.26 millionMPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), reports its IFRS Group results for the first quarter of 2015.
In the first quarter 2015 the MPH Group achieved sales of EUR 52.75 million
(prior-year period: EUR 56.17 million). Net profit for the period was
EUR 1.26 million (prior-year period: EUR 2.95 million).
In the pharma segment (HAEMATO AG) sales and net profit were below the level of the previous year period. From July 2014 to April 2015 tightenings in the pharmaceutical regulations led to a considerable reduction of the stock turn rate. For the period from May to December 2015 we are confident, that HAMEATO will reach good results. In good time to the lifting of the tightenings of the pharmaceutical regulations HAEMATO has doubled the production capacities. HAEMATO has the capacities to catch up, which was achieved less in the first quarter 2015.
In the field of medical aesthetics (M1 Med Beauty AG) an admission for the hospital at the Berlin location has been issued. With immediate effect the M1
Med Beauty Berlin GmbH is able to expand its market share with 40 %
higher capacity. The product division, comprising the sale of medicinal products for medical aesthetics, is in the process of obtaining the manufacturing license. M1 Aesthetics GmbH plans to market medicinal products as manufacturer henceforward.
In the Ruhr area the next M1-location will be established in 2015. The value added in the real-estate tenure business will be developed in the Healthcare Real Estate segment.
For the optimisation of the liabilities side as well as of the financing of further dynamic growth, MPH AG has successfully issued at short notice two more bonded loans totalling EUR 10,000,000.00.
MPH Mittelständische Pharma Holding AG Linda Reichelt
Fasanenstraße 77 Phone +49 (0) 30 897 30 86 60 E-Mail: ir@mph-ag.de
D-10623 Berlin Fax: +49 (0) 30 897 30 86 69 Web: www.mph-ag.de
Corporate NewsMay 29, 2015
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments of the
healthcare market and is aimed to make a contribution towards cutting costs
in the healthcare system.
Medicines, services for individual patient therapies, aesthetic surgeries and other medical treatments are offered along the value-added-chain in the healthcare market.
The MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) on the Frankfurt stock exchange.
Details for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
Contact: Linda Reichelt
MPH Mittelständische Pharma Holding AG Fasanenstraße 77
D-10623 Berlin
Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: ir@mph-ag.deWeb: www.mph-ag.de
MPH Mittelständische Pharma Holding AG Linda Reichelt
Fasanenstraße 77 Phone +49 (0) 30 897 30 86 60 E-Mail: ir@mph-ag.de
D-10623 Berlin Fax: +49 (0) 30 897 30 86 69 Web: www.mph-ag.de
|
distributed by
|
